Abstract
Introduction: Thromboembolism is one of the common complications in patients presenting with coronavirus disease 2019. Studies on coronavirus disease 2019 patients recommend the use of anticoagulation to prevent thrombotic complications in these patients and have shown to decrease mortality. However, spontaneous retroperitoneal bleeding is one of the life-threatening complications of therapeutic anticoagulation. Case Report: This case report is about an 82-year-old male who was admitted for coronavirus disease 2019 pneumonia, started on therapeutic dose anticoagulation on presentation, and developed life-threatening retroperitoneal bleeding. He was managed with conservative treatment because of the advanced age of the patient, high risk of deterioration, and guarded prognosis. Conclusion: Although anticoagulation protects against the thrombotic complications of coronavirus-19 infection, it has life-threatening bleeding complications. The use of anticoagulation in these patients should be practiced with caution while monitoring for bleeding complications. There needs to be more clinical studies and trials to assess the risk-benefit ratio of anticoagulation in coronavirus disease 2019 patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
